Normal levels of serum glycoproteins maintained in β-1,4-galactosyltransferase I-knockout mice  by Kido, Masahiro et al.
Normal levels of serum glycoproteins maintained in
L-1,4-galactosyltransferase I-knockout mice
Masahiro Kidoa;b, Masahide Asanoc, Yoichiro Iwakurac, Masao Ichinoseb, Kazumasa Mikid,
Kiyoshi Furukawaa;*
aDepartment of Biosignal Research, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan
bDepartment of Gastroenterology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan
cCenter for Experimental Medicine, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-0071, Japan
dThe First Department of Internal Medicine, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan
Received 22 November 1999
Edited by Guido Tettamanti
Abstract The galactose-mediated clearance of serum glycopro-
teins from the circulation was evaluated using L-1,4-galactosyl-
transferase (L-1,4-GalT) I-knockout mice. Partial structural
study of the oligosaccharides released from mouse serum
glycoproteins revealed that 77.4% of the oligosaccharides from
L-1,4-GalT I+/+ mouse contain galactose, while 7.7% of those
from L-1,4-GalT I^/^ mouse were galactosylated. Under the
conditions, no significant change in serum protein concentrations
was observed between the normal and mutant mice. The results
indicate that the hepatic asialoglycoprotein receptor-mediated
system is not functioning in the clearance of endogenous serum
glycoproteins.
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1. Introduction
One of the important functions of the carbohydrate moiety
of glycoproteins was brought about by the fortuitous ¢nding
that administration of desialylated ceruloplasmin into rabbits
resulted in rapid clearance from the circulation when com-
pared to the fully sialylated protein which survived for days
[1]. The subsequent studies dealing with a variety of serum
glycoproteins which were treated with sialidase and/or L-gal-
actosidase or galactose-oxidase and then injected into animals
established that the rapid uptake of these serum glycoproteins
is solely due to the exposure of the penultimate galactose
residues (reviewed in [2]). Accumulation of radiolabeled asia-
loglycoproteins in liver showed the presence of a unique re-
ceptor on the sinusoidal surface of hepatocytes which func-
tions in the binding, internalization and degradation of
galactose-terminated serum glycoproteins [3]. The asialoglyco-
protein receptor (ASGP-R) has been isolated from several
mammalian liver tissues [4^7] and found to be an oligomer
of two types of similar polypeptides, each of which binds a
galactose residue with a low a⁄nity [8^13]. However, oligo-
saccharides with speci¢c geometric arrangement of galactose
residues as in the GalL1C4GlcNAcL1C2ManK1C6-
[GalL1C4GlcNAcL1C4(GalL1C4GlcNAcL1C2)-
ManK1C3]Man structure bind the receptor with higher a⁄n-
ities ([14,15] and reviewed in [16]). Furthermore, since the
presence of the GalL1C3GlcNAc group on the non-reducing
termini of oligosaccharides diminishes a binding a⁄nity [17],
the presence of the GalL1C4GlcNAc groups on the non-re-
ducing termini of oligosaccharides is important for the clear-
ance of serum glycoproteins.
In the present study serum protein concentrations and the
galactose contents of serum glycoproteins were determined in
order to evaluate the biological signi¢cance of the galactose-
mediated clearance system of serum glycoproteins from the
circulation in L-1,4-galactosyltransferase (L-1,4-GalT) I-
knockout mice [18].
2. Materials and methods
2.1. Lectin blot analysis of serum glycoproteins and determination of
serum protein concentrations
The serum samples were obtained by the conventional method from
L-1,4-GalT I= and L-1,4-GalT I3=3 mice of 1, 6 and 8 weeks old
which were raised as described previously [18]. A portion of the sam-
ples was defatted with acetone and then with chloroform and meth-
anol mixtures (2:1 and 1:2, v/v), and the remaining portion was di-
luted with water by 100-fold and used for determination of protein
concentrations with a BCA protein assay kit [19]. The defatted sam-
ples were lyophilized and subjected to SDS-polyacrylamide (7.5%) gel
electrophoresis (SDS-PAGE) and transferred to polyvinylidenedi£uo-
ride (PVDF) membranes. Western blot analysis using biotinylated
Psathyrella velutina lectin (PVL) and peroxidase-conjugated Ricinus
communis agglutinin (RCA)-I was performed after treatment of blots
with Arthrobacter ureafaciens sialidase as described previously [18,20].
The blots were incubated with Coomassie Brilliant Blue (CBB) for
detecting protein bands or blocked with 1% bovine serum albumin
(BSA) prior to incubation with lectin. In some experiments, the blots
blocked with BSA were treated with 200 mU of diplococcal L-galac-
tosidase in 150 Wl of 0.3 M citrate phosphate bu¡er (pH 6.0) or 2.5 U
of N-glycanase in 150 Wl of 0.1 M phosphate bu¡er (pH 8.2) prior to
incubation with lectin.
2.2. Lectin column chromatography of N-linked oligosaccharides
released from serum glycoproteins
The serum glycoprotein samples from 6 weeks old mice (10 mg
each), which were dried thoroughly over P2O5 in vacuo, were sub-
jected to hydrazinolysis for 10 h as described previously [21]. After N-
acetylation, the liberated oligosaccharides were reduced with NaB3H4
to obtain tritium-labeled oligosaccharides for partial structural anal-
ysis. The radioactive oligosaccharides were directly digested with sia-
lidase in 50 Wl of 0.5 M acetate bu¡er (pH 5.0), and then applied to a
DEAE-Sepharose column. The oligosaccharides obtained in the pass-
through fraction of the column, which were supposed to be a mixture
of neutral and desialylated neutral ones, were fractionated by RCA-I-
agarose column chromatography. In some experiments, oligosaccha-
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rides were further separated by sequential column chromatography
using concanavalin A (Con A)-Sepharose and Aleuria aurantia lectin
(AAL)-Sepharose, and partial structures of oligosaccharides frac-
tionated were determined by combination of Bio-Gel P-4 column
(50 cm long) chromatography and exoglycosidase digestion according
to the methods described previously [22].
2.3. Chemicals, enzymes and lectin
RCA-I-agarose, peroxidase-conjugated RCA-I, diplococcal L-galac-
tosidase, jack bean L-N-acetylhexosaminidase and jack bean K-man-
nosidase were obtained from Seikagaku Kogyo Co. (Tokyo). Con A-
Sepharose and BCA protein assay kit were purchased from Pharmacia
Fine Chemical Co. (Tokyo) and Pierce (Rockford, IL), respectively.
A. ureafaciens sialidase, avidine-peroxidase, 4-chloro-1-naphthol and
hydrogen peroxide were obtained from Nacalai Tesque Co. (Kyoto).
NaB3H4 (490 mCi/mmol) was obtained from New England Nuclear
(Boston, MA). AAL-Sepharose, biotinylated P. velutina lectin (PVL),
and recombinant N-glycanase were gifts from Dr. N. Kochibe in
Gunma University, Nichirei Co. (Tokyo), and Dr. T. Kaizu previ-
ously in Genzyme Japan Co. (Tokyo), respectively.
2.4. Oligosaccharides
GalL1C4GlcNAcL1C2ManK1C6(GalL1C4GlcNAcL1C2Man-
K1C3)ManL1C4GlcNAcL1C4GlcNAcOT (Gal2WGlcNAc2WMan3W
GlcNAcWGlcNAcOT) was prepared from recombinant human factor
VIII, and its digestion products, GlcNAc2WMan3WGlcNAcWGlcNAcOT,
Man3WGlcNAcWGlcNAcOT and ManWGlcNAcWGlcNAcOT, were pre-
pared by treatments with respective glycosidases [23]. Subscript OT
indicates an NaB3H4-reduced oligosaccharide.
3. Results
3.1. Lectin blot analysis of mouse serum glycoproteins
In order to examine the expression of the GalL1C4Glc-
NAc group on individual serum glycoproteins, the samples
from L-1,4-GalT I= and L-1,4-GalT I3=3 mice of 1, 6 and
8 weeks old were subjected to lectin blot analysis. Coomassie
Brilliant Blue (CBB)-staining showed that numbers and inten-
sities in the staining of protein bands are almost the same
among the samples (Fig. 1, CBB), indicating that the serum
components are not changed between normal and mutant
mice and among their ages. After A. ureafaciens sialidase
treatment of blots, they were incubated with RCA-I, which
preferentially interacts with oligosaccharides terminated with
the GalL1C4GlcNAc group [24]. Many protein bands of
L-1,4-GalT I= mouse samples reacted strongly with RCA-
I (lanes A, B and C in Fig. 1, RCA-I), while only several
protein bands had week reactivities towards the lectin in
L-1,4-GalT I3=3 mouse samples (lanes AP, BP and CP in Fig.
1, RCA-I). Upon treatment of blots with diplococcal L-ga-
lactosidase, which cleaves the GalL1C4GlcNAc linkage but
not the GalL1C3GlcNAc linkage [25], prior to incubation
with lectin, no RCA-I-reactive bands were obtained in all
samples (the result from 8 weeks old L-1,4-GalT I3=3 mouse
sample is shown as a representative in lane CP-1 of Fig. 1,
RCA-I). Blots were also treated with N-glycanase and then
incubated with the lectin. No RCA-I-positive bands were also
detected in all samples (the result from 8 weeks old L-1,4- GalT I3=3 mouse sample is shown as a representative in
lane CP-2 of Fig. 1, RCA-I). These results indicate that
RCA-I-positive oligosaccharides contain terminal L-1,4-linked
galactose residue(s) and that serum glycoproteins from L-1,4-
GalT I3=3 mice also contain N-linked oligosaccharides with
L-1,4-linked galactose residues whose amounts are small. In
order to con¢rm that ungalactosylated oligosaccharides are
terminated with L-N-acetylglucosamine residues, lectin blot
analysis was performed using PVL which interacts oligosac-
charides terminated with L-N-acetylglucosamine [26]. The re-
Fig. 1. Western blot analysis of mouse serum glycoproteins. The se-
rum samples were from L-1,4-GalT I= (lanes A, B and C) and
L-1,4-GalT I3=3 (lanes AP, BP and CP) mice of 1 week old (lanes A
and AP), 6 weeks old (lanes B and BP) and 8 weeks old (lanes C
and CP), respectively. CBB: ¢lters were stained with Coomassie Bril-
liant Blue. RCA-I: ¢lters were incubated with RCA-I before (lanes
A, B, C, AP, BP and CP) and after treatment with diplococcal L-ga-
lactosidase (lane CP-1) or N-glycanase (lane CP-2). PVL: ¢lters were
incubated with PVL before (lanes A, B, C, AP, BP and CP) and after
treatment with jack bean L-N-acetylhexosaminidase (lane CP-1P) or
N-glycanase (lane CP-2).
Table 1
Relative amounts of neutral and desialylated neutral oligosaccha-
rides fractionated by RCA-I-agarose column chromatography
Fractions Relative amounts (%)
Genotype +/+ Genotype 3/3
RCA-I3 22.6 92.3
RCA-Ir 10.4 4.2
RCA-I 67.0 3.5
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sults showed that strong lectin reactivities are observed to-
wards most protein bands in L-1,4-GalT I3=3 mouse samples
(lanes AP, BP and CP in Fig. 1, PVL) in contrast to those from
L-1,4-GalT I= mouse samples (lanes A, B and C in Fig. 1,
PVL). Upon treatment of blots containing the mutant mouse
samples with jack bean L-N-acetylhexosaminidase or N-glyca-
nase, no lectin-reactive bands were obtained (the results from
8 weeks old L-1,4-GalT I3=3 mouse sample are shown as
representatives in lanes CP-1P and CP-2, respectively, in Fig.
1, PVL). Since most lectin-positive bands disappeared when
¢lters were treated with N-glycanase, lectin reactivities re£ect
the glycosylation status of N-linked oligosaccharides. There-
fore, the results indicate that most complex-type oligosaccha-
rides of serum glycoproteins from L-1,4-GalT I3=3 mice are
terminated with L-N-acetylglucosamine residues which are
supposed to be sugar acceptors of L-1,4-GalT I.
3.2. Partial structures of N-linked oligosaccharides released
from mouse serum glycoproteins
N-linked oligosaccharides were released from serum glyco-
proteins of 6 weeks old L-1,4-GalT I= and L-1,4-GalT I3=3
mice by hydrazinolysis, and the oligosaccharides were reduced
with NaB3H4. Almost the same amounts of radioactivities
were incorporated into two samples (data not shown), indicat-
ing that the same amounts of oligosaccharides are obtained
from L-1,4-GalT I= and L-1,4-GalT I3=3 mouse serum gly-
coprotein samples. After sialidase digestion, the radioactive
oligosaccharides were applied to a DEAE-Sepharose column,
and the pass-through fraction, in which more than 90% of the
applied oligosaccharides were recovered, was subjected to
RCA-I-agarose column chromatography. The pass-through
fraction (RCA-I3), the fraction that was retarded in the col-
umn (RCA-Ir) and the fraction that was bound and eluted
from the column with 10 mM lactose (RCA-I) were ob-
tained. The amounts of oligosaccharides in each fraction
were calculated on the basis of the radioactivities in the frac-
tions, and are summarized in Table 1. In the case of L-1,4-
GalT I= mouse sample, 22.6, 10.4 and 67.0% of the oligo-
saccharides were separated into fractions RCA-I3, RCA-Ir
and RCA-I, respectively. In contrast, 92.3, 4.2 and 3.5% of
the oligosaccharides from L-1,4-GalT I3=3 mouse sample
were separated into fractions RCA-I3, RCA-Ir and RCA-
I, respectively. Since oligosaccharides in fractions RCA-Ir
and RCA-I are considered to have one and more than two
L-1,4-linked galactose residues under the present condition
respectively, about 90% of the previously galactosylated N-
linked oligosaccharides of mouse serum glycoproteins were
ungalactosylated by ablation of mouse L-1,4-GalT I gene. In
order to con¢rm this further, bi-antennary complex-type oli-
gosaccharides, most of which were recovered in fraction
RCA-I in the case of L-1,4-GalT I= mouse and in fraction
RCA-I3 in the case of L-1,4-GalT I3=3 mouse were analyzed
by Bio-Gel P-4 column chromatography. Oligosaccharides in
fraction RCA-I from L-1,4-GalT I= mouse sample were
subjected to Con A-Sepharose column chromatography, and
fractions Con A3, Con A and Con A were obtained by
elution with bu¡er only and bu¡er with 5 mM K-methyl-glu-
coside and 100 mM K-methyl-mannoside, respectively. Oligo-
saccharides in fraction RCA-IWCon A were then separated
into those with (AAL) and without (AAL3) a fucose residue
attached to the proximal N-acetylglucosamine by AAL-
Sepharose column chromatography [22]. When fraction
RCA-IWCon AWAAL3 (39.6% of the total oligosaccharides)
was applied to a Bio-Gel P-4 column, a single peak was eluted
at the same position as authentic Gal2WGlcNAc2WMan3W
GlcNAcWGlcNAcOT (Fig. 2A). The peak in Fig. 2A was di-
gested with diplococcal L-galactosidase, and the product was
eluted at the same position as authentic GlcNAc2WMan3W
GlcNAcWGlcNAcOT, releasing two galactose residues (Fig.
Fig. 2. Sequential exoglycosidase digestion of bi-antennary complex-
type oligosaccharides. The fraction and its digestion products were
analyzed by Bio-Gel P-4 column chromatography: (A) fraction
RCA-I WCon A WAAL3 from L-1,4-GalT I= sample; (B) oligosac-
charide in panel A digested with diplococcal L-galactosidase; (C)
the peak in panel B digested with jack bean L-N-acetylhexosamini-
dase; (D) fraction RCA-I3WAAL3 from L-1,4-GalT I3=3 sample
after digestion with jack bean K-mannosidase; (E) oligosaccharide
indicated by a bar in panel D digested with diplococcal L-galactosi-
dase; (F) the peak in panel E digested with jack bean L-N-acetyl-
hexosaminidase. The numbers at the top of the ¢gure indicate glu-
cose units, and the arrows i, ii, iii and iv indicate the elution
positions of authentic oligosaccharides: i, ManWGlcNAcWGlcNAcOT ;
ii, Man3WGlcNAcWGlcNAcOT ; iii, GlcNAc2WMan3WGlcNAcWGlcNAcOT ;
iv, Gal2WGlcNAc2WMan3WGlcNAcWGlcNAcOT.
Table 2
Protein concentrations in mouse sera
Age (weeks) Protein concentrations (mg/ml)
Genotype +/+ Genotype 3/3
1 37.1 þ 2.18 33.4 þ 1.75
6 54.1 þ 2.87 50.9 þ 3.18
8 66.7 þ 3.19 59.7 þ 3.27
Values from three animals for each point are given as means þ
standard deviations.
FEBS 23110 16-12-99
M. Kido et al./FEBS Letters 464 (1999) 75^79 77
2B). Upon digestion of the product in Fig. 2B with jack bean
L-N-acetylhexosaminidase, the product was eluted at the same
position as authentic Man3WGlcNAcWGlcNAcOT, releasing two
N-acetylglucosamine residues (Fig. 2C). Oligosaccharides in
fraction RCA-I3 from L-1,4-GalT I3=3 mouse sample were
separated by AAL-Sepharose column chromatography, and
those in fraction RCA-I3WAAL3 was digested with jack
bean K-mannosidase to convert high mannose-type oligosac-
charides into ManWGlcNAcWGlcNAcOT (5.5 glucose units) for
separating them from complex-type oligosaccharides on a Bio-
Gel P-4 column. When they were applied to the column, four
peaks with e¡ective sizes of 14.2, 13.2, 11.2 and 5.5 glucose
units were obtained (Fig. 2D). The peak indicated by a bar in
Fig. 2D (51.6% of the total oligosaccharides) was digested
with diplococcal L-galactosidase, and the product was eluted
at the same position as one in Fig. 2D and authentic
GlcNAc2WMan3WGlcNAcWGlcNAcOT, indicating that no galac-
tose residues are released (Fig. 2E). Upon digestion of the
product in Fig. 2E with jack bean L-N-acetylhexosaminidase,
the product was eluted at the same position as authentic
Man3WGlcNAcWGlcNAcOT, releasing two N-acetylglucosamine
residues (Fig. 2F). When peaks with e¡ective sizes of 14.2 and
13.2 glucose units were digested separately with jack bean
L-N-acetylhexosaminidase, the products were eluted at the
same position as authentic Man3WGlcNAcWGlcNAcOT, releas-
ing three and four N-acetylglucosamine residues, respectively
(data not shown). That the products with an e¡ective size of
7.2 glucose units in Fig. 2C and F have the structure Man-
K1C6(ManK1C3)ManL1C4GlcNAcL1C4GlcNAcOT was
con¢rmed by the methods described earlier [22]. These results
indicate that bi-antennary complex-type oligosaccharides in
fraction RCA-IWCon AWAAL3 from L-1,4-GalT I= mouse
sample are fully galactosylated while those in fraction RCA-
I3W-AAL3 from L-1,4-GalT I3=3 mouse sample are totally
ungalactosylated. Similar results were obtained by analyzing
bi-antennary complex-type oligosaccharides in fraction RCA-
IWCon AWAAL from L-1,4-GalT I= mouse sample and
fraction RCA-I3WAAL from L-1,4-GalT I3=3 mouse sample
(data not shown). When oligosaccharides in fraction RCA-Ir
from L-1,4-GalT I= mouse sample and those in fractions
RCA-Ir and RCA-I from L-1,4-GalT I3=3 mouse sample
were digested with diplococcal L-galactosidase, most of the
oligosaccharides were passed through an RCA-I-agarose col-
umn (data not shown), indicating that these oligosaccharides
contain L-1,4-linked galactose residues and that 7.7% of the
N-linked oligosaccharides of L-1,4-GalT I3=3 mouse serum
glycoproteins still contain L-1,4-linked galactose residues.
3.3. Determination of mouse serum protein concentrations
The results described above showed that most serum glyco-
proteins of L-1,4-GalT I3=3 mice are extremely undergalacto-
sylated. If the galactose residues are really important for clear-
ance of serum glycoproteins, it is expected that sera from
L-1,4-GalT I3=3 mice should contain higher concentrations
of proteins due to the defect in the turnover of proteins.
The serum samples obtained from L-1,4-GalT I= and
L-1,4-GalT I3=3 mice were diluted with water, and protein
concentrations were determined by the BCA method [19].
As shown in Table 2, no signi¢cant di¡erence but a slight
decrease in protein concentrations was found in L-1,4-GalT
I3=3 mouse serum samples when compared to those of the
age-matched L-1,4-GalT I= mice. However, there were age-
related di¡erences in the protein concentrations of both L-1,4-
GalT I= and L-1,4-GalT I3=3 mice. The protein concentra-
tions appeared to increase with the growth of animals. The
results are also quite consistent with those obtained by lectin
blot analysis in which the CBB-staining of serum protein
bands was almost similar between L-1,4-GalT I= and
L-1,4-GalT I3=3 mice of the same ages as shown in Fig. 1.
These results indicate that no speci¢c proteins are selectively
eliminated from the circulation in L-1,4-GalT I3=3 mice.
4. Discussion
It is known that elimination of serum glycoproteins from
the circulation is mediated by ASGP-R which recognizes the
terminal galactose residues of the glycoproteins after desialy-
lation most probably with sialidase [27]. Since the receptor has
higher a⁄nity binding to the 2,4-branched tri-antennary com-
plex-type oligosaccharides with L-1,4-linked galactose residues
[14,15], animals without expressing the galactose residues
could not survive due to higher viscosity of blood by the
accumulated proteins. However, L-1,4-GalT I-knockout mice
can survive up to the birth without problems in the circulation
[18,28]. The present study revealed that serum glycoproteins
from L-1,4-GalT I-knockout mice of three di¡erent ages lack
most L-1,4-linked galactose residues. The partial structural
analysis of N-linked oligosaccharides, however, revealed that
10% of the previously galactosylated oligosaccharides still
contain L-1,4-linked galactose residues which are formed
most probably by some of novel L-1,4-GalTs II, III, IV and
V recently discovered (reviewed in [29]). Nevertheless, the se-
rum protein concentrations in the mutant mice were shown to
be in the similar levels to those of the normal mice although
the age-dependent di¡erences were found in the protein con-
centrations. This indicates strongly that the terminal L-1,4-
linked galactose residues are not directly involved in the clear-
ance of endogenous serum glycoproteins from the circulation.
In support of this, it has been reported that serum concen-
trations of the galactose-terminated glycoproteins are not ele-
vated in the ASGP-R-de¢cient mice [30,31]. Furthermore, no
apparent charge di¡erences were observed in human Q-gluta-
myltransferase with di¡erently sialylated forms puri¢ed be-
tween rat liver and rat serum after injection, indicating that
no prior desialylation is required for elimination of serum
glycoproteins from the circulation [32]. Determination of se-
rum protein concentrations showed that a slight decrease in
the protein concentrations is associated with L-1,4-GalT I3=3
mice, which could be due to the ine⁄cient secretion of these
glycoproteins by the defective glycosylation since it has been
shown that inhibition of the glycosylation disturbs protein
secretion [33]. These results indicate that the clearance of se-
rum glycoproteins is regulated by some mechanism(s) other
than the ASGP-R-mediated uptake. Nevertheless, speci¢c
degradation of 125I-labeled asialo-K1 acid glycoprotein by pri-
mary cultured mouse hepatocytes [31] indicates that the
ASGP-R-mediated clearance mechanism is e¡ective for elim-
inating the glycoproteins whose galactose residues are exposed
under some unphysiological conditions such as virus/bacteria
infection [27] probably because the exposed sugar residues
could be harmful to the vascular system [34].
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